Publications by authors named "Kenneth Alan Howard"

Claim this Profile
T
Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness.
Bradley Whitehead, LinPing Wu, Michael Lykke Hvam, Husnu Aslan, Mingdong Dong, Kenneth Alan Howard

J Extracell Vesicles· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycation-based nanoparticles for RNAi-mediated cancer treatment.
Borja Ballarín-González, Morten Frendø Ebbesen, Kenneth Alan Howard

Cancer Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The application of RNAi-based treatments for inflammatory bowel disease.
Morten Tobias Jarlstad Olesen, Borja Ballarín-González, Kenneth Alan Howard

Drug Deliv Transl Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical translation of RNAi-based treatments for respiratory diseases.
Borja Ballarín-González, Troels Bo Thomsen, Kenneth Alan Howard

Drug Deliv Transl Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions.
Borja Ballarín-González, Kenneth Alan Howard

Adv Drug Deliv Rev· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery.
Menglin Chen, Shan Gao, Mingdong Dong, Jie Song, Chuanxu Yang, Kenneth Alan Howard

ACS Nano· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
Morten Østergaard Andersen, Kenneth Alan Howard, Jørgen Kjems

Methods Mol Biol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.
Alpesh Mistry, Sys Zoffmann Glud, Jørgen Kjems, Jens Randel, Kenneth Alan Howard

J Drug Target· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering the goods: realizing the clinical potential of RNAi.
Kenneth Alan Howard

Nanomedicine (Lond)· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of RNA interference therapeutics using polycation-based nanoparticles.
Kenneth Alan Howard

Adv Drug Deliv Rev· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.
Shan Gao, Frederik Dagnaes-Hansen, Ebbe Juel Bech Nielsen, Jesper Wengel, Flemming Besenbacher, Kenneth Alan Howard

Mol Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration.
Sys Zoffmann Glud, Jesper B Bramsen, Frederik Dagnaes-Hansen, Jesper Wengel, Kenneth Alan Howard

Oligonucleotides· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of polyplex-based DNA vaccines.
Kenneth Alan Howard, H Oya Alpar

J Drug Target· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis